1-8 of 8
Shikiko Ueno, MD.
Close
Sort by
Journal Articles

PU.1-Induced IRF4 Down-Regulation and Subsequent IRF7 up-Regulation in Myeloma Cells

Niina Ueno, MD, Shikiko Ueno, MD PhD, Shinya Endo, MD, Nao Nishimura, MD, Hiro Tatetsu, MD PhD, Shinya Hirata, MD PhD, Hiroaki Mitsuya, MD PhD, Yutaka Okuno, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2957.
https://doi.org/10.1182/blood.V126.23.2957.2957
Published: 2015
Journal Articles

Conditional Knockout of Sfpi1 in Post GC B and Plasma Cells Induces B Cell Lymphoma and Plasma Cell Neoplasm

Shinya Endo, MD, Hiromichi Yuki, MD PhD, Yoshihiro Komohara, MD PhD, Shikiko Ueno, MD PhD, Nao Nishimura, MD, Niina Ueno, MD, Hiro Tatetsu, MD PhD, Motohiro Takeya, MD PhD, Hiroyuki Hata, MD PhD, Seiji Okada, MD PhD, Daniel G. Tenen, MD, Hiroaki Mitsuya, MD PhD, Yutaka Okuno, MD PhD
Journal: Blood
Blood (2014) 124 (21): 29.
https://doi.org/10.1182/blood.V124.21.29.29
Published: 2014
Journal Articles

Xenograft Models of Multiple Myeloma Reveal That PU.1 Serves As a Tumor Suppressor for Multiple Myeloma

Nao Nishimura, MD, Shinya Endo, MD, Niina Ueno, MD, Shikiko Ueno, MD PhD, Hiromichi Yuki, MD PhD, Hiroyuki Hata, MD PhD, Hiroaki Mitsuya, MD PhD, Yutaka Okuno, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2047.
https://doi.org/10.1182/blood.V124.21.2047.2047
Published: 2014
Journal Articles

SALL4 Is a Key Factor in HDAC Inhibitor Mediated Ex Vivo Expansion of Human Peripheral Blood Mobilized Stem/Progenitor CD34+CD90+ Cells

Hiro Tatetsu, MD PhD, Fei Wang, Chong Gao, MD PhD, Shikiko Ueno, MD PhD, Xi Tian, BS, Myriam Armant, PhD, Alex Federation, Jun Qi, PhD, James E. Bradner, Daniel G. Tenen, MD, Li Chai, MD
Journal: Blood
Blood (2014) 124 (21): 1566.
https://doi.org/10.1182/blood.V124.21.1566.1566
Published: 2014
Journal Articles

A Novel Approach in Expanding CD34+CD90+ and CD34+CD38-CD90+ Cells Associated with Enhanced in Vivo Repopulating potential.

Hiro Tatetsu, MD, PhD, Chong Gao, MD, PhD, Shikiko Ueno, MD, PhD, Daniel G Tenen, MD, Li Chai, MD
Journal: Blood
Blood (2012) 120 (21): 2337.
https://doi.org/10.1182/blood.V120.21.2337.2337
Published: 2012
Journal Articles

PU.1-Induced Growth Arrest and Apoptosis in Classical Hodgkin Lymphoma Cells

Hiromichi Yuki, MD, Shikiko Ueno, MD, PhD, Hiroaki Niiro, MD, PhD, Hiro Tatetsu, MD, PhD, Hiroyuki Hata, MD, PhD, Toshiki Watanabe, MD, PhD, Seiji Okada, MD, Ph.D, Koichi Akashi, MD, PhD., Hiroaki Mitsuya, Professor, Yutaka Okuno, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2628.
https://doi.org/10.1182/blood.V118.21.2628.2628
Published: 2011
Journal Articles

SALL4 Is a Key Survival Factor in Acute B-Cell Lymphoblastic Leukemia

Shikiko Ueno, MD, PhD, Jiayun Lu, PhD, He Jie, PhD, Ailing Li, PhD, XiaoXian Zhang, Leslie E Silberstein, MD, Jerome Ritz, MD, Li Chai, MD
Journal: Blood
Blood (2011) 118 (21): 2428.
https://doi.org/10.1182/blood.V118.21.2428.2428
Published: 2011
Journal Articles

PU.1 Is Downregulated in a Subset of Multiple Myeloma by the Methylation of Its -17 kb Upstream Regulatory Region and the Promoter.

Yutaka Okuno, MD, PhD, Hiro Tatetsu, MD.PhD., Shikiko Ueno, MD., Hiroyuki Hata, MD.PhD., Yasuhiro Yamada, MD.PhD., Motohiro Takeya, MD.PhD., Tadafumi Iino, MD, Koichi Akashi, MD.PhD., Daniel G. Tenen, MD., Hiroaki Mitsuya, MD.PhD.
Journal: Blood
Blood (2006) 108 (11): 3417.
https://doi.org/10.1182/blood.V108.11.3417.3417
Published: 2006